Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo ® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment ...

Libtayo was the sixth PD-L/PD-L1 inhibitor to reach the market, starting out as a therapy for another skin cancer called cutaneous squamous cell carcinoma (CSCC), and the rarity of that disease ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results ...

The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology.

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results demonstrat ...

A series where we find out which products the professionals (who really know what they’re talking about) actually use and really stand behind. Read more here. Building a skin-care routine for ...

Feb. 12, 2025 — Researchers have achieved a breakthrough in wearable health technology by developing a novel self-healing electronic skin (E-Skin) that repairs itself in seconds after damage ...

An exanthem is any eruptive skin rash that may be associated with fever or other systemic symptoms. Causes include infectious pathogens, medication reactions and, occasionally, a combination of both.

Irritants such as detergents and bleach can cause irritant contact dermatitis. Allergic contact dermatitis happens due to an allergic reaction to a particular substance, such as poison ivy or ...

It also leaves you prone to rashes, says Palep, which can’t be addressed with just moisturizer. So you’ll want to lotion up early and often to avoid all that. Below, I’ve compiled the best ...

After hours: February 14 at 7:59:43 PM EST Loading Chart for REGN ...